from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0081/-

LFCtreatmentdescriptionclass of inhibitor

0.698

Amikacinug/mL Amikacintranslation

0.166

Cap5-10ug/mL Capreomycintranslation

0.182

Rox10-50 ug/mL Roxithromycintranslation

0.001

SM2-5 ug/mL Streptomycintranslation

0.267

Tet5-10 ug/mL Tetracyclinetranslation

0.730

Rif0.2-5ug/mL Rifampicintranscription

-0.072

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.031

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.266

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.277

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.092

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.027

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.809

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.838

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.591

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.287

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.086

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.242

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.165

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.516

KCN5-20 ug/mL Potassium cyaniderespiration

-0.026

NaN30.2-2 mM Sodium aziderespiration

-0.261

Nigericin50 uM Nigericinrespiration

0.275

TRC10-150 ug/mL Triclosanrespiration

-2.031

TRZ10-25 ug/mL Thioridazinerespiration

-0.029

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.307

menadione6-10 ug/mL Menadionerespiration

-0.010

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.125

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.340

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.965

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.550

NRP_1Non-replicating persistence stage 1dosRassociated

-0.445

Amp0.2mg/mL AmpicillincellWall

-0.519

Cephalexin20-100 ug/mL CephalexincellWall

-0.320

Cerulenin0.32-5 ug/mL CerulenincellWall

0.228

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.236

EMB10-20 ug/mL EthambutolcellWall

-0.033

Eta12-40 ug/mL EthionamidecellWall

-0.067

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.041

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.272

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.258

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.027

BZA0.12 mg/mL BenzamidearomaticAmides

0.136

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.043

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.091

H2O24 mM hydrogen peroxideDNAdamaging

0.381

Levo10 ug/mL LevofloxacinDNAdamaging

-0.237

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.801

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.359

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.222

UVUV-irradiationDNAdamaging

-0.760

ARP41-4 ug/mL Antitubercular compound ARP4?

0.305

Antimycin12.5-50 ug/mL Antimycin A?

0.333

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.272

PA_110-50 ug/mL Antitubercular compound PA-1?

0.038

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.078

PA8240.2-2 ug/mL PA-824?

1.583

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.421

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.402

Verapamil50 uM Verapamil?

-0.149

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.555

methoxatin10-20 ug/mL Methoxatin?